Caxton Associates LLP Medpace Holdings, Inc. Transaction History
Caxton Associates LLP
- $4.11 Billion
- Q3 2025
A detailed history of Caxton Associates LLP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 20,804 shares of MEDP stock, worth $12.3 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
20,804Holding current value
$12.3 Million% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding MEDP
# of Institutions
734Shares Held
24.8MCall Options Held
104KPut Options Held
187K-
Black Rock Inc. New York, NY2.58MShares$1.52 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$1.35 Billion0.02% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.03MShares$605 Million0.35% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT926KShares$546 Million2.66% of portfolio
-
State Street Corp Boston, MA673KShares$397 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $18.4B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...